Combination formulations have become a fixture of repair-focused peptide research, and two of the most requested are KLOW and GLOW. They are closely related — but not interchangeable — and understanding the difference matters for study design.
What GLOW Contains
GLOW combines three compounds: GHK-Cu, the copper-binding tripeptide central to collagen and remodeling research; BPC-157, the stable gastric-derived peptide dominating preclinical repair literature; and TB-500, the thymosin beta-4 fragment studied in cell migration. Together they cover signaling, repair, and migration — a skin-and-matrix oriented research stack.
Technical Composition of the GLOW Peptide Blend
KLOW contains the same three compounds plus KPV, the alpha-MSH fragment studied in inflammation signaling and barrier biology. The addition points the blend toward research questions where inflammatory pathways sit alongside repair — gut barrier models being the obvious example in the literature.
Choosing Between Them
The practical distinction: GLOW for skin, collagen, and matrix-focused designs; KLOW when the study design also involves inflammation or barrier endpoints. Laboratories running single-variable designs can source each component individually from our Recovery/Inflammation and Anti-Aging collections.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.